BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37392551)

  • 1. LncRNA PVT1 promotes bladder cancer progression by forming a positive feedback loop with STAT5B.
    Li Z; Fu H; Liu J; Song W; Zeng M; Wang J
    Pathol Res Pract; 2023 Aug; 248():154635. PubMed ID: 37392551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA PVT1 regulates growth, migration, and invasion of bladder cancer by miR-31/ CDK1.
    Tian Z; Cao S; Li C; Xu M; Wei H; Yang H; Sun Q; Ren Q; Zhang L
    J Cell Physiol; 2019 Apr; 234(4):4799-4811. PubMed ID: 30317572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA PVT1 accelerates malignant phenotypes of bladder cancer cells by modulating miR-194-5p/BCLAF1 axis as a ceRNA.
    Chen M; Zhang R; Lu L; Du J; Chen C; Ding K; Wei X; Zhang G; Huang Y; Hou J
    Aging (Albany NY); 2020 Nov; 12(21):22291-22312. PubMed ID: 33188158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of long noncoding RNA PVT1 suppresses cell proliferation and invasion of colorectal cancer via upregulation of microRNA-214-3p.
    Shang AQ; Wang WW; Yang YB; Gu CZ; Ji P; Chen C; Zeng BJ; Wu JL; Lu WY; Sun ZJ; Li D
    Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G222-G232. PubMed ID: 31125260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-Myc-activated long non-coding RNA PVT1 enhances the proliferation of cervical cancer cells by sponging miR-486-3p.
    Wang C; Zou H; Chen A; Yang H; Yu X; Yu X; Wang Y
    J Biochem; 2020 Jun; 167(6):565-575. PubMed ID: 31943014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Positive Feedback Loop of lncRNA-
    Xu MD; Wang Y; Weng W; Wei P; Qi P; Zhang Q; Tan C; Ni SJ; Dong L; Yang Y; Lin W; Xu Q; Huang D; Huang Z; Ma Y; Zhang W; Sheng W; Du X
    Clin Cancer Res; 2017 Apr; 23(8):2071-2080. PubMed ID: 27756785
    [No Abstract]   [Full Text] [Related]  

  • 7. LncRNA PVT1 contributes to invasion and doxorubicin resistance of bladder cancer cells through promoting MDM2 expression and AURKB-mediated p53 ubiquitination.
    Jiang X; Li H; Fang Y; Xu C
    Environ Toxicol; 2022 Jun; 37(6):1495-1508. PubMed ID: 35213076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of LncRNA PVT1 inhibits tumorigenesis in non-small-cell lung cancer by regulating miR-497 expression.
    Guo D; Wang Y; Ren K; Han X
    Exp Cell Res; 2018 Jan; 362(1):172-179. PubMed ID: 29133127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long Noncoding RNA PVT1 Silencing Prevents the Development of Uveal Melanoma by Impairing MicroRNA-17-3p-Dependent MDM2 Upregulation.
    Wu S; Chen H; Han N; Zhang C; Yan H
    Invest Ophthalmol Vis Sci; 2019 Nov; 60(14):4904-4914. PubMed ID: 31770435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA PVT1 promotes breast cancer proliferation and metastasis by binding miR-128-3p and UPF1.
    Liu S; Chen W; Hu H; Zhang T; Wu T; Li X; Li Y; Kong Q; Lu H; Lu Z
    Breast Cancer Res; 2021 Dec; 23(1):115. PubMed ID: 34922601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA
    Chen D; Chen J; Gao J; Zhang Y; Ma Y; Wei W; Wei Y
    Cancer Biother Radiopharm; 2020 Jun; 35(5):319-328. PubMed ID: 32412777
    [No Abstract]   [Full Text] [Related]  

  • 12. Long Noncoding RNA Plasmacytoma Variant Translocation 1 (PVT1) Promotes Colon Cancer Progression via Endogenous Sponging miR-26b.
    Zhang R; Li J; Yan X; Jin K; Li W; Liu X; Zhao J; Shang W; Liu Y
    Med Sci Monit; 2018 Dec; 24():8685-8692. PubMed ID: 30504754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA PVT1 regulates VEGFC through inhibiting miR-128 in bladder cancer cells.
    Yu C; Longfei L; Long W; Feng Z; Chen J; Chao L; Peihua L; Xiongbing Z; Hequn C
    J Cell Physiol; 2019 Feb; 234(2):1346-1353. PubMed ID: 30076714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA PVT1 promotes angiogenesis via activating the STAT3/VEGFA axis in gastric cancer.
    Zhao J; Du P; Cui P; Qin Y; Hu C; Wu J; Zhou Z; Zhang W; Qin L; Huang G
    Oncogene; 2018 Jul; 37(30):4094-4109. PubMed ID: 29706652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LINC00612 enhances the proliferation and invasion ability of bladder cancer cells as ceRNA by sponging miR-590 to elevate expression of PHF14.
    Miao L; Liu HY; Zhou C; He X
    J Exp Clin Cancer Res; 2019 Apr; 38(1):143. PubMed ID: 30940184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA PVT1 facilitates cell migration and invasion by regulating miR-148a-3p and ROCK1 in breast cancer.
    Li HL; Wang CP; Zhang Y; Du JX; Han LH; Yang HY
    Clin Transl Oncol; 2022 May; 24(5):882-891. PubMed ID: 34859371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of long noncoding RNA PVT1 inhibits esophageal carcinoma cell migration and invasion and promotes cell apoptosis via microRNA-145-mediated inhibition of FSCN1.
    Shen SN; Li K; Liu Y; Yang CL; He CY; Wang HR
    Mol Oncol; 2019 Dec; 13(12):2554-2573. PubMed ID: 31369196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense lncRNA-RP11-498C9.13 promotes bladder cancer progression by enhancing reactive oxygen species-induced mitophagy.
    Song W; Li Z; Yang K; Gao Z; Zhou Q; Li P
    J Gene Med; 2023 Sep; 25(9):e3527. PubMed ID: 37382425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOX2 knockdown slows cholangiocarcinoma progression through inhibition of transcriptional activation of lncRNA PVT1.
    Yu A; Zhao L; Kang Q; Li J; Chen K; Fu H
    Biochem J; 2020 Sep; 477(18):3527-3540. PubMed ID: 32812642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA PVT1 promotes laryngeal squamous cell carcinoma development by acting as a molecular sponge to regulate miR-519d-3p.
    Zheng X; Zhao K; Liu T; Liu L; Zhou C; Xu M
    J Cell Biochem; 2019 Mar; 120(3):3911-3921. PubMed ID: 30304557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.